Calendar Akari Therapeutics, Plc

Equities

AKTX

US00972G2075

Market Closed - Nasdaq 04:30:00 2024-04-25 pm EDT 5-day change 1st Jan Change
1.19 USD 0.00% Intraday chart for Akari Therapeutics, Plc -1.65% -61.86%

Chart calendar Akari Therapeutics, Plc

95a9b0e1aa144f88ea544.VNxmyWyklSfZumfIRCJkyAfOwPPJLxsWZz4wIlxG8Vw.Zrc_8AbMo26I6j28fGUXrTGq852Hey0uAF8GTz00phgHkiuzDcXUUZaIEA~188a2a80629f4038f59bf5e665dd17aa

Upcoming events on Akari Therapeutics, Plc

2024-05-05 04:00 pm Association for Research in Vision and Ophthalmology Meeting
2024-05-29 Q1 2024 Earnings Release (Projected)
2024-09-25 Q2 2024 Earnings Release (Projected)
2025-04-07 Q4 2024 Earnings Release (Projected)
2025-09-24 Q2 2025 Earnings Release (Projected)

Past events on Akari Therapeutics, Plc

2024-04-01 06:30 am Q4 2023 Earnings Release
2024-01-08 12:30 pm JPMorgan Healthcare Conference
2023-11-15 03:00 pm Dry AMD Therapeutic Development Conference
2023-10-19 11:30 am Investor Meeting - Key Opinion Leader
2023-10-04 11:25 am Emerging Growth Conference
2023-09-29 08:00 am Q2 2023 Earnings Release
2023-06-30 09:00 am Anuual General Meeting
2023-05-22 A.G.P Virtual Healthcare Conference
2023-05-22 02:00 pm Investor Meeting - Key Opinion Leader
2023-05-01 08:00 am Q4 2022 Earnings Release
2023-04-23 02:30 am European Society for Blood and Marrow Transplantation Meeting
2023-01-09 09:00 am Biotech Showcase
2022-12-08 01:45 pm Cantor Fitzgerald Medical & Aesthetic Dermatology, Ophthalmology & MedTech Conference
2022-11-29 09:30 am BTIG Ophthalmology Day
2022-11-14 Jefferies London Healthcare Conference
2022-11-09 01:45 pm Sidoti Virtual Micro Cap Conference
2022-09-28 09:00 am Cantor Oncology, Hematology & HemeOnc Conference
2022-09-27 08:00 am Interim 2022 Earnings Release
2022-07-20 06:00 am Q1 2022 Earnings Release
2022-06-30 09:30 am Annual General Meeting

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00


0,00


0,00
0,00
-
EBITDA
Released
Forecast
Spread
0,00
0,00
-
0,00


0,00


0,00
0,00
-
EBIT
Million USD
Released
Forecast
Spread
-17,0
-15,0
-13.47%
0,00


0,00


-23,1
-22,6
-2.34%
Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-17,1
-15,0
-14.04%
0,00


0,00


-17,7
-22,3
20.5%
Net income
Million USD
Released
Forecast
Spread
-17,1
-15,1
-13.66%
0,00


-17,4


-17,7
-21,0
15.53%
EPS
USD
Released
Forecast
Spread
-0,20
-0,20
0%
-0,20


0,00


0,00
-2,90
-
Announcement Date31/03/2020/04/2116/05/2201/05/23

Quarterly results

Fiscal PeriodDecember 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2
Net sales
Million USD
Released
Forecast
Spread




0,00

0,00
0,00
-






EBIT
Million USD
Released
Forecast
Spread




-5,75


-6,00







Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-5,68














Net income
Million USD
Released
Forecast
Spread
-5,68



-4,51


-5,49







EPS
USD
Released
Forecast
Spread




-0,40


-0,70


-1,20

0,00
-1,00
-
Announcement Date27/09/22-01/05/23-29/09/23

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. AKTX Stock
  4. Calendar Akari Therapeutics, Plc